The core-binding factor leukemias: lessons learned from murine models
- 24 January 2003
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Genetics & Development
- Vol. 13 (1), 48-54
- https://doi.org/10.1016/s0959-437x(02)00018-7
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Core-binding factors in haematopoiesis and leukaemiaNature Reviews Cancer, 2002
- The Role of the AML1 Transcription Factor in LeukemogenesisInternational Journal of Hematology, 2001
- AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AMLOncogene, 2001
- Structural Analyses of DNA Recognition by the AML1/Runx-1 Runt Domain and Its Allosteric Control by CBFβCell, 2001
- Dimerization with PEBP2beta protects RUNX1/AML1 from ubiquitin-proteasome-mediated degradationThe EMBO Journal, 2001
- Targeted Disruption of Results in a Complete Lack of Bone Formation owing to Maturational Arrest of OsteoblastsCell, 1997
- Cbfa1, a Candidate Gene for Cleidocranial Dysplasia Syndrome, Is Essential for Osteoblast Differentiation and Bone DevelopmentCell, 1997
- The CBFβ Subunit Is Essential for CBFα2 (AML1) Function In VivoCell, 1996
- Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis.Proceedings of the National Academy of Sciences of the United States of America, 1996
- AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver HematopoiesisCell, 1996